Objective: This study tested two family-based interventions designed for delivery in usual care: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA), containing motivational interventions, homework management and schoolwork organization training, and family-school partnership building; and Medication Integration Protocol (MIP), containing ADHD psychoeducation, medication decision-making, and integrated medication management.Method: This study used a cluster randomized design to test CASH-AA + MIP versus CASH-AA Only for adolescents with ADHD in five sites. Therapists (N = 49) were site clinicians randomized to condition. Clients (N = 145) included 72% males; 42% White Non-Hispanic, 37% Hispanic American, 15% African American, and 6% more than one race; average age was 14.8 years. Fidelity data confirmed protocol adherence and between-condition differentiation. Results: One-year improvements were observed across conditions in several outcomes. Overall, CASH-AA + MIP produced greater declines in adolescent-report inattentive symptoms and delinquent acts. Similarly, among non-substance users, CASH-AA + MIP clients attended more treatment sessions. In contrast, among substance users, CASH-AA Only clients showed greater declines in caregiver-report hyperactive symptoms and externalizing.Conclusions: This study provides initial experimental support for family-based ADHD medication decision-making when coupled with academic training in usual care. The treatment protocols, CASH-AA and MIP, showed positive effects in addressing not only ADHD symptoms but also common co-occurring problems, and youth with substance use problems benefitted along with non-using peers.
Objective: This study tested two family-based interventions designed for delivery in usual care: Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA), containing motivational interventions, homework management and schoolwork organization training, and family-school partnership building; and Medication Integration Protocol (MIP), containing ADHD psychoeducation, medication decision-making, and integrated medication management.Method: This study used a cluster randomized design to test CASH-AA + MIP versus CASH-AA Only for adolescents with ADHD in five sites. Therapists (N = 49) were site clinicians randomized to condition. Clients (N = 145) included 72% males; 42% White Non-Hispanic, 37% Hispanic American, 15% African American, and 6% more than one race; average age was 14.8 years. Fidelity data confirmed protocol adherence and between-condition differentiation. Results: One-year improvements were observed across conditions in several outcomes. Overall, CASH-AA + MIP produced greater declines in adolescent-report inattentive symptoms and delinquent acts. Similarly, among non-substance users, CASH-AA + MIP clients attended more treatment sessions. In contrast, among substance users, CASH-AA Only clients showed greater declines in caregiver-report hyperactive symptoms and externalizing.Conclusions: This study provides initial experimental support for family-based ADHD medication decision-making when coupled with academic training in usual care. The treatment protocols, CASH-AA and MIP, showed positive effects in addressing not only ADHD symptoms but also common co-occurring problems, and youth with substance use problems benefitted along with non-using peers.
Authors: David Daley; Saskia Van Der Oord; Maite Ferrin; Samuele Cortese; Marina Danckaerts; Manfred Doepfner; Barbara J Van den Hoofdakker; David Coghill; Margaret Thompson; Philip Asherson; Tobias Banaschewski; Daniel Brandeis; Jan Buitelaar; Ralf W Dittmann; Chris Hollis; Martin Holtmann; Eric Konofal; Michel Lecendreux; Aribert Rothenberger; Paramala Santosh; Emily Simonoff; Cesar Soutullo; Hans Christoph Steinhausen; Argyris Stringaris; Eric Taylor; Ian C K Wong; Alessandro Zuddas; Edmund J Sonuga-Barke Journal: J Child Psychol Psychiatry Date: 2017-10-30 Impact factor: 8.982
Authors: Catherine C Davis; Milena Claudius; Lawrence A Palinkas; John B Wong; Laurel K Leslie Journal: J Atten Disord Date: 2011-10-05 Impact factor: 3.256
Authors: Maite Ferrin; J M Moreno-Granados; M D Salcedo-Marin; M Ruiz-Veguilla; V Perez-Ayala; E Taylor Journal: Eur Child Adolesc Psychiatry Date: 2013-12-01 Impact factor: 4.785
Authors: D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar Journal: J Clin Psychiatry Date: 1998 Impact factor: 4.384
Authors: Susanna N Visser; Melissa L Danielson; Rebecca H Bitsko; Joseph R Holbrook; Michael D Kogan; Reem M Ghandour; Ruth Perou; Stephen J Blumberg Journal: J Am Acad Child Adolesc Psychiatry Date: 2013-11-21 Impact factor: 8.829
Authors: Margaret H Sibley; Stefany J Coxe; Mark A Stein; Michael C Meinzer; Matthew J Valente Journal: J Am Acad Child Adolesc Psychiatry Date: 2021-06-05 Impact factor: 13.113